Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCH-IV international treatment protocol for children and adolescents with Langerhans cell histiocytosis
NL-OMON50201Phase 3Recruiting
- Sponsor
- SKion
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinblastine, prednisone, mercaptopurine, cytarabine, vincristine in Langerhans cell histiocytosis (LCH), central nervous system Langerhans cell histiocytosis (CNS-LCH), sponsored by SKion. Started Jan 2014; status: recruiting.
02
Drugs
vinblastineprednisonemercaptopurinecytarabinevincristine
03
Conditions
Langerhans cell histiocytosis (LCH)central nervous system Langerhans cell histiocytosis (CNS-LCH)
Beyond the preview
Go deeper on NL-OMON50201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50201.